Organogenesis Holdings

Organogenesis Holdings

World Rank (Aug-2026)
14999
Market Cap (Aug-2026)
0.230 Billion USD
Market Cap (Mar-08-2026)
0.359 Billion USD
World Rank (Jan-05-2024)
12,742
Market Cap (Jan-05-2024)
0.490 Billion USD
World Rank (Jul-30-2023)
12,042
Market Cap (Jul-30-2023)
0.560 Billion USD
World Rank (Jan-07-2022)
9,086
Market Cap (Jan-07-2022)
1.057 Billion USD
World Rank (Jan-01-2021)
8,103
Market Cap (Jan-01-2021)
0.962 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
ORGO
Employee Count
950
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
564 Million USD
Annual Operating Income in USD
45 Million USD
Annual Net Income in USD
37 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
599 Million USD
Total Liabilities in USD
165 Million USD
Total Equity in USD
300 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
Company Website
ORGANOGENESIS HOLDINGS
Yahoo
Yahoo @ Nasdaq
Company Profile
Organogenesis Holdings is a Regenerative Medicine company focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care and surgical and sports medicine markets. The headquarters is in USA.
Facts About Company
Organogenesis Holdings company annual revenue was 450 million USD and annual net income was 15 million USD as on Dec-2022.
Founded Year
1985
IPO Year
2016
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share